LOGO
LOGO

X4 Pharmaceuticals, Inc. (XFOR)

  • X4 Pharma Q1 Net Loss $20.2 Mln Or $0.16/Shr Vs Net Income $0.3 Mln Or $0.04/Shr Last Year 5/6/2026 7:53:25 AM
  • X4 Pharmaceuticals Says EC Grants Marketing Authorization For XOLREMDI Capsules For WHIM Syndrome In European Union 4/29/2026 7:28:58 AM
  • X4 Pharma Q4 Net Loss $23.9 Mln Or $0.22/Shr Vs Loss $39.6 Mln Or $5.89/Shr Last Year 3/17/2026 7:17:52 AM
  • Older Articles
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap